Market Cap | 1.37B | P/E | 17.84 | EPS this Y | -57.80% | Ern Qtrly Grth | - |
Income | -148.46M | Forward P/E | 10.21 | EPS next Y | 39.70% | 50D Avg Chg | -14.00% |
Sales | 1.84B | PEG | 1.33 | EPS past 5Y | -20.37% | 200D Avg Chg | -28.00% |
Dividend | 5.00% | Price/Book | 1.53 | EPS next 5Y | 6.81% | 52W High Chg | -42.00% |
Recommedations | 3.00 | Quick Ratio | 1.02 | Shares Outstanding | 49.70M | 52W Low Chg | - |
Insider Own | 2.26% | ROA | 3.78% | Shares Float | 48.66M | Beta | 1.13 |
Inst Own | 87.17% | ROE | -18.78% | Shares Shorted/Prior | 2.57M/2.67M | Price | 27.47 |
Gross Margin | 71.14% | Profit Margin | -8.05% | Avg. Volume | 765,767 | Target Price | 11.17 |
Oper. Margin | 5.42% | Earnings Date | Oct 30 | Volume | 994,867 | Change | -7.63% |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
DA Davidson | Neutral | Aug 12, 24 |
Citigroup | Neutral | Aug 9, 24 |
DA Davidson | Neutral | May 9, 24 |
DA Davidson | Neutral | Jan 5, 24 |
Stifel | Hold | Oct 16, 23 |
Citigroup | Neutral | Sep 29, 23 |
DA Davidson | Neutral | Aug 3, 23 |
Stifel | Hold | Aug 2, 23 |
DA Davidson | Neutral | May 19, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
LIPMAN ANDREW D | Director Director | Jan 25 | Sell | 18.55 | 2,000 | 37,100 | 31,225 | 01/25/24 |
LIPMAN ANDREW D | Director Director | Dec 26 | Sell | 19.39 | 2,000 | 38,780 | 33,225 | 12/27/23 |
LIPMAN ANDREW D | Director Director | Nov 27 | Sell | 17.11 | 2,000 | 34,220 | 35,225 | 11/28/23 |
LIPMAN ANDREW D | Director Director | Nov 03 | Sell | 17.68 | 15,400 | 272,272 | 37,225 | 11/06/23 |
LIPMAN ANDREW D | Director Director | Oct 25 | Sell | 19.23 | 2,000 | 38,460 | 52,625 | 10/26/23 |
LIPMAN ANDREW D | Director Director | Sep 25 | Sell | 23.02 | 2,000 | 46,040 | 54,625 | 09/25/23 |
LIPMAN ANDREW D | Director Director | Aug 25 | Sell | 23.33 | 2,000 | 46,660 | 56,625 | 08/28/23 |
Nathanson Laura | Director Director | Aug 21 | Sell | 24.12 | 6,068 | 146,360 | 10,300 | 08/22/23 |
Battle Emma S. | Director Director | Aug 07 | Sell | 26.15 | 1,272 | 33,263 | 7,619 | 08/08/23 |
LIPMAN ANDREW D | Director Director | Jul 25 | Sell | 28.99 | 2,000 | 57,980 | 58,625 | 07/25/23 |
LIPMAN ANDREW D | Director Director | Jun 26 | Sell | 32.12 | 2,000 | 64,240 | 60,625 | 06/26/23 |
WOODBURY EDWINA D | Director Director | May 09 | Sell | 37.87 | 1,255 | 47,527 | 15,469 | 05/09/23 |
LIPMAN ANDREW D | Director Director | Apr 25 | Sell | 40.75 | 2,000 | 81,500 | 60,393 | 04/25/23 |
LIPMAN ANDREW D | Director Director | Mar 27 | Sell | 39.29 | 2,000 | 78,580 | 62,393 | 03/27/23 |
Hatchett Steven Keith | Chief Product Office.. Chief Product Officer | Mar 09 | Sell | 39.78 | 21,155 | 841,546 | 58,368 | 03/09/23 |
Hatchett Steven Keith | Chief Product Office.. Chief Product Officer | Mar 09 | Option | 30.45 | 21,155 | 644,170 | 79,523 | 03/09/23 |
NAPIERSKI RYAN S | President and CEO President and CEO | Feb 27 | Sell | 40.91 | 31,513 | 1,289,197 | 168,784 | 02/28/23 |
NAPIERSKI RYAN S | President and CEO President and CEO | Feb 27 | Option | 30.63 | 31,513 | 965,243 | 178,784 | 02/28/23 |
Battle Emma S. | Director Director | Feb 22 | Sell | 41.70 | 987 | 41,158 | 4,659 | 02/23/23 |
LIPMAN ANDREW D | Director Director | Feb 22 | Sell | 41.42 | 1,000 | 41,420 | 64,393 | 02/23/23 |
Thomas James D | Chief Accounting Off.. Chief Accounting Officer | Feb 22 | Sell | 41.12 | 2,829 | 116,328 | 17,928 | 02/23/23 |
LIPMAN ANDREW D | Director Director | Jan 23 | Sell | 42.27 | 1,000 | 42,270 | 65,393 | 01/23/23 |
CHANG JOSEPH Y | Chief Scientific Off.. Chief Scientific Officer | Dec 18 | Option | 37.58 | 6,800 | 255,544 | 29,757 | 12/20/22 |
LIPMAN ANDREW D | Director Director | Nov 22 | Sell | 38.16 | 1,000 | 38,160 | 67,393 | 11/22/22 |
LIPMAN ANDREW D | Director Director | Sep 22 | Sell | 36.67 | 1,000 | 36,670 | 69,393 | 09/22/22 |
Thomas James D | Chief Accounting Off.. Chief Accounting Officer | Sep 07 | Sell | 39.19 | 1,602 | 62,782 | 12,722 | 09/08/22 |
NAPIERSKI RYAN S | President and CEO President and CEO | Aug 25 | Option | 34.11 | 25,000 | 852,750 | 147,683 | 08/25/22 |
NAPIERSKI RYAN S | President and CEO President and CEO | Aug 25 | Sell | 42.99 | 25,000 | 1,074,750 | 122,683 | 08/25/22 |
LIPMAN ANDREW D | Director Director | Aug 22 | Sell | 45.01 | 1,000 | 45,010 | 70,393 | 08/22/22 |
Hatchett Steven Keith | Chief Product Office.. Chief Product Officer | Aug 18 | Sell | 46.78 | 5,500 | 257,290 | 49,431 | 08/19/22 |
LIPMAN ANDREW D | Director Director | Jul 22 | Sell | 43.00 | 1,000 | 43,000 | 71,393 | 07/22/22 |
LUND STEVEN | Exec. Chairman of th.. Exec. Chairman of the Board | Jun 23 | Sell | 45.11 | 17,129 | 772,689 | 20,800 | 06/23/22 |
LIPMAN ANDREW D | Director Director | Jun 22 | Sell | 44.06 | 1,000 | 44,060 | 72,393 | 06/22/22 |
LUND STEVEN | Exec. Chairman of th.. Exec. Chairman of the Board | Jun 17 | Sell | 45.02 | 8,126 | 365,833 | 22,975 | 06/22/22 |
LUND STEVEN | Exec. Chairman of th.. Exec. Chairman of the Board | Jun 13 | Sell | 44.43 | 51,695 | 2,296,809 | 27,000 | 06/15/22 |
Lawrence Mark H | Chief Financial Offi.. Chief Financial Officer | Jun 06 | Sell | 47.03 | 5,868 | 275,972 | 48,218 | 06/08/22 |
CHANG JOSEPH Y | Chief Scientific Off.. Chief Scientific Officer | Jun 01 | Option | 30.63 | 16,000 | 490,080 | 38,957 | 06/02/22 |
CHANG JOSEPH Y | Chief Scientific Off.. Chief Scientific Officer | Jun 01 | Sell | 46.61 | 16,000 | 745,760 | 22,957 | 06/02/22 |
NAPIERSKI RYAN S | President and CEO President and CEO | May 25 | Option | 34.11 | 25,000 | 852,750 | 147,683 | 05/26/22 |
NAPIERSKI RYAN S | President and CEO President and CEO | May 25 | Sell | 44.84 | 25,000 | 1,121,000 | 122,683 | 05/26/22 |
LIPMAN ANDREW D | Director Director | May 23 | Sell | 44.95 | 1,000 | 44,950 | 70,214 | 05/23/22 |
LUND STEVEN | Exec. Chairman of th.. Exec. Chairman of the Board | May 16 | Sell | 45.66 | 22,125 | 1,010,227 | 179,449 | 05/18/22 |
LIPMAN ANDREW D | Director Director | Apr 22 | Sell | 47.72 | 1,000 | 47,720 | 71,214 | 04/22/22 |
LIPMAN ANDREW D | Director Director | Mar 22 | Sell | 47.40 | 1,000 | 47,400 | 72,214 | 03/23/22 |
NAPIERSKI RYAN S | President and CEO President and CEO | Feb 25 | Option | 34.11 | 25,000 | 852,750 | 147,683 | 03/01/22 |
NAPIERSKI RYAN S | President and CEO President and CEO | Feb 25 | Sell | 47.49 | 25,000 | 1,187,250 | 122,683 | 03/01/22 |
LIPMAN ANDREW D | Director Director | Jan 24 | Sell | 50.50 | 1,000 | 50,500 | 74,214 | 01/24/22 |
CHANG JOSEPH Y | EVP, Chief Scientifi.. EVP, Chief Scientific Officer | Sep 13 | Sell | 47.41 | 16,000 | 758,560 | 17,942 | 09/13/21 |
CHANG JOSEPH Y | EVP, Chief Scientifi.. EVP, Chief Scientific Officer | Sep 13 | Option | 30.63 | 16,000 | 490,080 | 33,942 | 09/13/21 |
WOOD RITCH N | Chief Executive Offi.. Chief Executive Officer | Jun 21 | Sell | 58.29 | 36,500 | 2,127,585 | 175,239 | 06/21/21 |